Topics

Meningioma | Treatment | Immunotherapy

Home > Publications > Topics > Meningioma > Treatment > Immunotherapy

Rath S, Shafeea MS, Abdul Hussein AF, Shamil Hashim A, Hassanaien S, Pastrana-Brandes S, Chaurasia B.
CAR-T-cell therapy in meningioma: current investigations, advancements and insight into future directions.
Ann Med Surg (Lond). 2024 Aug 22;86(10):5957-5965. doi: 10.1097/MS9.0000000000002491. PMID: 39359850. Review. ˍ

*White AJ, Harary M, Casaos J, Everson RG.
Current immunotherapy techniques in meningioma.
Expert Rev Anticancer Ther. 2024 Sep 4:1-11. doi: 10.1080/14737140.2024.2399252. PMID: 39233324. Review˰ ˍ

Huang J, Johanns TM, Campian JL, Chicoine M, Zipfel G, Chheda M, Butt O, Ivanov D, Chernyshov K, Salem B, Tkachuk A, Frank A, Klimova D, Tabakov D, Harmanci AS, Chen WC, Patel AJ, Raleigh DR, Kim AH, Chen CK.
A phase I window-of-opportunity study of neoadjuvant avelumab and hypofractionated radiation therapy in radiation-relapsed meningioma.
medRxiv [Preprint]. 2025 Sep 28:2025.09.26.25336740. doi: 10.1101/2025.09.26.25336740. PMID: 41040714. Interventional study. ˍ